Evotec and Serono sign agreement
Evotec OAI and Serono have announced a services agreement under which Evotec will develop a novel biological assay for one of Serono's cellular targets using Serono's proprietary VLiP technology.
Evotec OAI and Serono have announced a services agreement under which Evotec will develop a novel biological assay for one of Serono's cellular targets using Serono's proprietary VLiP technology.